Loading...

/News/RNS

AIM Notice - 20/02/2025

RNS Announcement

RNS Number : 6862X

AIM

20 February 2025

NOTICE

20/02/2025 - 08:00

The London Stock Exchange admits the following securities to trading on AIM:

IMMUPHARMA PLC
81,086,667	ORDINARY SHARES OF 1P EACH, FULLY PAID	(3371101)(GB0033711010)

IMMUPHARMA PLC
2,200,000	ORDINARY SHARES OF 1P EACH, FULLY PAID	(3371101)(GB0033711010)

THOR ENERGY PLC
491,462,584	ORDINARY SHARES OF GBP0.001 EACH, FULLY PAID	(BRJ5231)(GB00BRJ52319)

If you have any queries or require further information, please contact Market Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AMOGIGDDRXBDGUC

RNS metadata

Title: AIM Notice - 20/02/2025
Time: 08:00:00
Date: 20 Feb 2025
Category: Corporate updates
ID: 6862X